← FDA Drug Approvals (Drugs@FDA)
IBUPROFEN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-09-14
Drug application
- FDA Application #
ANDA215777- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBUPROFEN
- Generic name
- IBUPROFEN
- Active ingredients
- IBUPROFEN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurohealth LLC
- First approval
- 2023-09-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown